Generation and phenotype of mice harboring a nonsense mutation in the V2 vasopressin receptor gene

被引:76
|
作者
Yun, J
Schöneberg, T
Liu, J
Schulz, A
Ecelbarger, CA
Promeneur, D
Nielsen, S
Sheng, H
Grinberg, A
Deng, CX
Wess, J
机构
[1] NIDDKD, Bioorgan Chem Lab, Bethesda, MD 20892 USA
[2] Free Univ Berlin, Inst Pharmakol, Fachbereich Humanmed, D-1000 Berlin, Germany
[3] Georgetown Univ, Dept Med, Div Endocrinol & Metab, Washington, DC 20057 USA
[4] Aarhus Univ, Inst Anat, Dept Cell Biol, DK-8000 Aarhus, Denmark
[5] NICHHD, Lab Mammalian Genes & Dev, Bethesda, MD 20892 USA
[6] NIDDKD, Biochem & Metab Lab, Bethesda, MD 20892 USA
来源
JOURNAL OF CLINICAL INVESTIGATION | 2000年 / 106卷 / 11期
关键词
D O I
10.1172/JCI9154
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The V2 vasopressin receptor (V2R) plays a key role in the maintenance of a normal body water balance. To generate an in vivo model that allows the physiological and molecular analysis of the role of V2Rs in kidney function, we have created mouse lines that lack functional V2Rs by using targeted mutagenesis in mouse embryonic stem cells. Specifically, we introduced a nonsense mutation known to cause X-linked nephrogenic diabetes insipidus (XNDI) in humans (Glu242stop) into the mouse genome. V2R-deficient hemizygous male pups showed a decrease in basal urine osmolalities and were unable to concentrate their urine. These pups also exhibited an enlargement of renal pelvic space, failed to thrive, and died within the first week after birth due to hypernatremic dehydration. Interestingly, female mice heterozygous for the V2R mutation showed normal growth but displayed an XNDI-like phenotype, characterized by reduced urine concentrating ability of the kidney, polyuria, and polydipsia. Western blot analysis and immunoelectron microscopic studies showed that the loss of functional V2Rs had no significant effect on the basal expression levels of aquaporin-2 and the bumetanide-sensitive Na-K-2Cl cotransporter (BSC-1). The V2R mutant mice described here should serve as highly useful tools for the development of novel therapeutic strategies for the treatment of XNDI.
引用
下载
收藏
页码:1361 / 1371
页数:11
相关论文
共 50 条
  • [21] Constitutive internalisation of the human V2 vasopressin receptor
    Hermosilla, R
    Schmidt, A
    Schwieger, I
    Oksche, A
    Schülein, R
    Wiesner, B
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2005, 371 : R18 - R19
  • [22] O-glycosylation of the V2 vasopressin receptor
    Sadeghi, H
    Birnbaumer, M
    GLYCOBIOLOGY, 1999, 9 (07) : 731 - 737
  • [23] A fully active nonglycosylated V2 vasopressin receptor
    Innamorati, G
    Sadeghi, H
    Birnbaumer, M
    MOLECULAR PHARMACOLOGY, 1996, 50 (03) : 467 - 473
  • [24] EVIDENCE FOR VASOPRESSIN V2 RECEPTOR REGULATION INVIVO
    KINTER, LB
    CALDWELL, N
    CALTABIANO, S
    BROOKS, DP
    ALBRIGHTSONWINSLOW, CR
    FASEB JOURNAL, 1988, 2 (04): : A928 - A928
  • [25] The V2 vasopressin receptor mutations and fluid homeostasis
    Birnbaumer, M
    CARDIOVASCULAR RESEARCH, 2001, 51 (03) : 409 - 415
  • [26] Characterization of truncated forms of V2 vasopressin receptor
    Innamorati, G
    Sadeghi, H
    Birnbaumer, M
    FASEB JOURNAL, 1996, 10 (06): : 2259 - 2259
  • [27] Constitutive internalisation of the human V2 vasopressin receptor
    Hermosilla, R
    Schmidt, A
    Schwieger, I
    Oksche, A
    Schülein, R
    Wiesner, B
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2005, 371 : R18 - R18
  • [28] MUTATIONS IN THE VASOPRESSIN V2 RECEPTOR GENE IN 2 FAMILIES WITH NEPHROGENIC DIABETES-INSIPIDUS
    HOLTZMAN, EJ
    KOLAKOWSKI, LF
    GEIFMANHOLTZMAN, O
    OBRIEN, DG
    RASOULPOUR, M
    GUILLOT, AP
    AUSIELLO, DA
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (02): : 169 - 176
  • [29] A NOVEL MUTATION IN VASOPRESSIN V2 RECEPTOR GENE CAUSING X-LINKED NEPHROGENIC DIABETES-INSIPIDUS IN A FAMILY
    CHEONG, HI
    PARK, HW
    HA, IS
    CHOI, Y
    KIDNEY INTERNATIONAL, 1995, 47 (01) : 344 - 344
  • [30] Constitutive internalisation of the V2 vasopressin receptor is independent of receptor activity
    Schmidt, A
    Schülein, R
    Wiesner, B
    Hermosilla, R
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2005, 371 : R23 - R24